Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
18%
Ph not_applicable
7
64%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(5)
Other(4)

Detailed Status

Completed5
unknown4
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (22.2%)
N/A7 (77.8%)

Trials by Status

unknown436%
active_not_recruiting19%
not_yet_recruiting19%
completed545%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11